65 related articles for article (PubMed ID: 15759959)
1. Recurrent extramedullary plasmacytoma in asymptomatic multiple myeloma: a case report.
Schols SE; Tick LL
J Med Case Rep; 2015 Feb; 9():37. PubMed ID: 25880694
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of solitary plasmacytoma in the liver 10 years after the onset of multiple bone lesions.
Numata J; Tsunemine H; Imai A; Nakamura N; Sakai T; Itoh T; Arima N
J Clin Exp Hematop; 2024; 64(1):65-70. PubMed ID: 38538320
[TBL] [Abstract][Full Text] [Related]
3. Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation.
Trullemans F; Schots R; Storme G; Camp BV
Bone Marrow Transplant; 2000 Jan; 25(1):115-7. PubMed ID: 10654026
[TBL] [Abstract][Full Text] [Related]
4. Extramedullary relapse in a patient with multiple myeloma: a rare cause of gastrointestinal perforation and massive bleeding.
Rene CG; Achiam MP; Salomo M; Penninga L
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34794974
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous plasmacytoma: a rare manifestation of multiple myeloma.
Carrai LHM; Machado ECFA; Castro L; Gontijo LM
An Bras Dermatol; 2024; 99(3):454-456. PubMed ID: 38402013
[No Abstract] [Full Text] [Related]
6. A single-centre retrospective review of treatment responses and adverse events of thalidomide in patients with inflammatory skin disease.
McSweeney SM; Mounsey S; Arujuna N; Garibaldinos T; Sarkany R; Fassihi H
Clin Exp Dermatol; 2024 Jan; 49(2):168-170. PubMed ID: 37652049
[No Abstract] [Full Text] [Related]
7. A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma.
Minarik J; Szotkowski T; Hrbek J; Krhovska P; Buriankova E; Proskova J; Pika T; Bacovsky J
Clin Case Rep; 2021 Aug; 9(8):e04570. PubMed ID: 34401156
[TBL] [Abstract][Full Text] [Related]
8. Breast plasmacytoma as a manifestation prior to relapse of multiple myeloma.
López Rodríguez E; Álvarez Pérez RM; Jiménez-Hoyuela García JM
Rev Clin Esp; 2021 Apr; 221(4):243-244. PubMed ID: 31806205
[No Abstract] [Full Text] [Related]
9. Transjugular Liver Biopsy in a Multiple Myeloma Patient with Hepatomegaly, Portal Hypertension and "Miliary" Liver Lesions: A Case Report.
Gonzalez-Aguirre AJ; Lin O; Cho C; Lesokhin AM; Maybody M
J Gastrointest Dig Syst; 2016 Feb; 6(1):. PubMed ID: 28775913
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic Multiple Myeloma Presenting as a Nodular Hepatic Lesion: A Case Report and Review of the Literature.
Huang H; Bazerbachi F; Mesa H; Gupta P
Ochsner J; 2015; 15(4):457-67. PubMed ID: 26730235
[TBL] [Abstract][Full Text] [Related]
11. Relapse of multiple myeloma presenting as extramedullary plasmacytomas in multiple organs.
Köse M; Buraniqi E; Akpinar TS; Kayacan SM; Tükek T
Case Rep Hematol; 2015; 2015():452305. PubMed ID: 25694834
[TBL] [Abstract][Full Text] [Related]
12. Imaging features of extramedullary, relapsed, and refractory multiple myeloma involving the liver across treatment with cyclophosphamide, lenalidomide, bortezomib, and dexamethasone.
Saboo SS; Fennessy F; Benajiba L; Laubach J; Anderson KC; Richardson PG
J Clin Oncol; 2012 Jul; 30(20):e175-9. PubMed ID: 22689802
[No Abstract] [Full Text] [Related]
13. Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas.
Bladé J; Perales M; Rosiñol L; Tuset M; Montoto S; Esteve J; Cobo F; Villela L; Rafel M; Nomdedeu B; Montserrat E
Br J Haematol; 2001 May; 113(2):422-4. PubMed ID: 11380408
[TBL] [Abstract][Full Text] [Related]
14. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
Zhong YP; Chen SL
Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
[TBL] [Abstract][Full Text] [Related]
15. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
16. Clinical assessment of bortezomib for multiple myeloma in comparison with thalidomide.
Satoh M; Oguro R; Yamanaka C; Takada K; Matsuura Y; Akiba T; Aotsuka N; Tani Y; Wakita H
J Pharm Pharm Sci; 2011; 14(1):78-89. PubMed ID: 21501555
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.
Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG
Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778
[TBL] [Abstract][Full Text] [Related]
18. Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide.
del Giglio A; Weinschenker P; Manhani AR; Carbonell AL; Mitteldorf CA
South Med J; 2005 Feb; 98(2):238-40. PubMed ID: 15759959
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
